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Endoglin is required to maintain normal cardiac function in adult life
Simon Tual-Chalot (1), Benjamin J Davison (1), Rachael E Redgrave (1), 
Elizabeth Greally (1), Christopher Nicholson (2), Oliver Smith (1), 
Michael Taggart (2), Helen M Arthur (1)
(1)Institute of Genetic Medicine, Newcastle University, Newcastle Upon 
Tyne, Royaume-Uni – (2) Institute of Cellular Medicine, Newcastle Uni-
versity, Newcastle Upon Tyne, Royaume-Uni
Endoglin protein (also known as CD105) is a co-receptor for members of 
the transforming growth factor-β (TGFβ) superfamily of ligands, and regulates 
angiogenesis. Patients carrying mutations in the endoglin gene develop the 
inherited vascular dysplasia, Hereditary Haemorrhagic Telangiectasia (HHT). 
In light of the growing clinical interest in endoglin function in cardiovascular 
disease, we aimed to determine its role by depleting endoglin in a mouse 
model during adult life and assess effects on cardiac function. Endoglin was 
depleted in adult Rosa26-Cre-ERT2;Engfl/fl mice using tamoxifen treatment 
to generate “ubiquitous” endoglin knockout (Eng-iKOu) mice and cardiac 
magnetic resonance imaging (MRI) was used to evaluate cardiac function at 
1, 3, 5 and 12 weeks after endoglin knockdown. Loss of endoglin leads to an 
enlarged heart and cardiomyocyte hypertrophy within 5 weeks and left ven-
tricular volumes continued to enlarge substantially over subsequent weeks. 
However, LV ejection fraction was not significantly altered in Eng-iKOu mice 
compared with controls suggesting that cardiac function was not impaired. To 
address whether the cardiac remodelling observed in Eng-iKOu mice was due 
to loss of endoglin in endothelial cells we used a transgenic Cre line 
(Cdh5Cre-ERT2) to generate endothelial specific depletion of endoglin (Eng-
iKOe). These mice showed a similar increase in heart mass and ventricular 
volumes to the Eng-iKOu mice. To investigate if vasomotor defects are 
contributing to the major cardiac remodelling, we analysed vasomotor func-
tion in the aortas of Eng-iKOe mice. We found an increased contraction 
response of the aorta to phenylephrine in Eng-iKOe mice compared to 
controls, suggesting that endoglin is important in controlling the aortic 
contractile response. These results describe a novel phenotype and highlight 
the importance of endothelial endoglin in the maintenance of cardiac structure 
and function.
0237
Gadd45 γ promotes cardiac dysfunction by inducing necroptosis 
pathway in a mouse model of chronic myocardial infarction
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Background: Postinfarction remodeling is accompanied and influenced by 
perturbations in MAPK signaling. The Growth arrest and DNA-damage-
inducible 45 (Gadd45) proteins are small acidic proteins involved in DNA 
repair and modulation of MAPK activities. Despite its relationship with p38 
MAPK, little is known about the role of Gadd45 in the heart. Our aim is to 
explore the potential contribution of Gadd45 gamma (γ) on heart failure devel-
opment after myocardial infarction (MI).
Methods and results: MI was induced in wild-type (WT) versus Gadd45 
γ (KO) mice by left anterior descending coronary artery ligation. Pre-MI, WT, 
and KO hearts had comparable chamber dimensions and ventricular function, 
but as early as 1 week post-MI, KO mice had significantly better cardiac func-
tion than WT mice. The left ventricular dilatation, dysfunction and fibrosis 
remained better in the KO mice throughout the study (4 weeks). We examined 
the infarct size following a 24-hour MI and found it to be decreased in the KO 
mice. In addition, necroptosis activity pathway (RIP1; caspase 8) was reduced 
in the KO mice. To mimic the Gadd45 γ overexpression observed during MI, 
we injected 3 10^11 of cTNT-Gadd45 γ AAV9 particles i.v. and studied the 
cardiac function. Four weeks after the cTNT-Gadd45 γ AAV9 injection, we 
observed a decrease in the cardiac function compared to the GFP-AAV9 
injected control mice. A remodeling process is engaging with more fibrosis. 
Gadd45 γ overexpression activated the necroptosis pathway through p38 
MAPK.
Conclusion: Gadd45 γ promotes ischemic injury, accentuates post-MI 
remodeling and left ventricular dysfunction, and increases the progression to 
heart failure. The lost of gadd45 γ confers resistance to ischemic injury, at 
least in part, via limiting necroptosis pathway through a p38 MAPK dependant 
mechanism. This work, demonstrate the importance of Gadd45 γ/p38 MAPK 
complex in the development of heart failure, particularly in the balance of the 
cell death process.
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Chronic activation of β-adrenergic (β-AR) pathway causes excessive 
accumulation of cAMP in cardiomyocytes and participates in pathological car-
diac remodeling leading to heart failure (HF). Cyclic nucleotide phosphodies-
terases (PDEs) are responsible for the degradation of cAMP and cGMP in 
subcellular compartments. Among the different PDE families, PDE2 is unique 
in being activated ~5-fold by cGMP, thus mediating a negative cross talk 
between cGMP and cAMP signaling. Recently, we found that PDE2A activity 
is increased in human HF and this may represent a protective mechanism lim-
iting β-AR cardiotoxicity in chronic HF. Our therapeutic strategy is to target 
PDE2 with specific activators to treat HF at the early stages. A PDE2 activity 
assay has been developed, first using a purified PDE2 from bovine adrenal 
glands, then using a commercial recombinant protein (full-length human 
PDE2A). We miniaturized a bioluminescent activity assay in 384 well plates, 
which was validated for High-Throughput Screening (HTS) with an excellent 
Z-factor (>0.7) on the Ciblot HTS platform. Moreover, an in silico screening 
based on the binding of molecules on the GAF-B domain (regulatory domain) 
of PDE2 has been performed on a large library of molecules. As a counter 
screen, a PDE4 assay has been employed to eliminate nonspecific modulators. 
Ranking of hits is based on activation efficacy in comparison to 5 μM cGMP, 
EC50, Emax and cytotoxicity following chemical resynthesis in a SAR (Struc-
ture Activity Relationship) strategy. Several complementary assays are cur-
rently under development to confirm the effect of the activators in a Hit to 
Lead process (cellular assays, cAMP ELISA, co-cristallisation, Biacore). This 
challenging project is supported by LabEx LERMIT within its new cardio-
vascular target program
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Cardiac activity of autoantibodies (AABs) directed against β1-adrenoceptor 
(β1-AR) has been proposed to play an important role in the pathogenesis of 
dilated cardiomyopathy. Our previous work has shown that the immunization 
of rats with the second extracellular loop (ECII) of β1-AR induced endothelial 
dysfunction in aorta and mesenteric arteries. However, until now, no study has 
explored the cardiovascular effects of β3-AABs alone or combined with 
β1-AABs.
Aim: To evaluate whether β3-AABs possess β3-AR agonistic effect and 
whether active immunization producing β3-AABs and/or β1-AABs has delete-
rious effects on cardiac and vascular reactivity in Lewis rats.
Methods: Lewis rats were immunized for 3 months with peptidic 
sequences corresponding to the ECII of β3-AR and/or β1-AR.? The agonistic 
effect of β3-AABs was evaluated on electrically field-stimulated isolated car-
diomyocytes from adult rabbit by measuring the cell shortening. Inotropy 
studies and isolated aorta and mesenteric artery studies were also conducted 
on immunized rats.
Results: SR58611A (10 nM), a preferential β3-AR agonist and purified 
β3-AABs (25 μg/mL) induced a decrease of cell shortening (–39.6±4.4% 
(n=11) and –18.5±3.9% (n=10) respectively). This decrease was significantly 
inhibited when the cardiomyocytes were preincubated with the L-748337 
(1 μM), a selective β3-AR antagonist (p<0.05). The cell shortening of cardio-
myocytes from rats immunized against the β1-AR, in response to isoprenaline 
(10 nM), was significantly decreased (p<0.05). In contrast, this effect was 
conserved in rats immunized against β3-AR or β3/β1-AR. Vasorelaxations 
induced by acetylcholine and SR58611A in both aorta and mesenteric arteries 
were unaltered by immunization.
These results show that β3-AABs induced a β3-AR agonist-like activity. 
They would not have a cardiovascular pathogenic action but would offset the 
cardiac and endothelial dysfunctions caused by β1-AABs.
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Background: MiR-378 and miR-378* microRNAs are derived from an 
intron of the PGC-1β gene, a regulator of mitochondrial biogenesis. Their 
expression is either repressed or increased during heart failure depending on 
the model. Through proteomics approaches, we previously identified new tar-
gets of these miRs in H9c2 fetal cardiomyoblasts, among which lactate dehy-
drogenase for miR-378 and key cytoskeletal proteins for miR-378*.
Aims: To better assess its role in energy metabolism and differentiation; 
we overexpressed miR-378 and miR-378* in primary neonate rat cardio-
myocytes (NRC) that are more differentiated and less proliferative than H9c2 
cardiomyoblasts.
Results: We identified desmin as a new target of miR-378* in NRC. 
Desmin network plays a key role as a structural integrator of myofibrils and 
mitochondria positioning. MiR-378* overexpression reduced desmin levels 
and disrupted its organization. Confocal microscopy analysis of NRC stained 
with the mitochondrial dye MitoTracker revealed that miR-378* overexpres-
sion alters mitochondria distribution in the cell. AAV-mediated rescue of 
desmin expression in presence of miR-378* preserved mitochondria distribu-
tion. Mir-378 overexpression had a milder impact on cell organization than 
miR-378* and did not directly targetted desmin.
Conclusion and perspectives: These results suggest that changes in miR-
378* expression level could play an important role in the coupled alteration of 
cytoskeletal and mitochondrial networks observed in failing myocardium.
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Alterations of cardiac function induced by postnatal overfeeding can 
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Postnatal overfeeding (OF) in rodents induces a permanent moderate 
increase in body weight, metabolic disorders and progressive alterations of 
cardiac function. Our aim was to determine whether moderate diet restric-
tion could restore cardiac function in mature overfed mice. Immediately 
after birth, litters of C57BL/6 mice were either maintained at nine (normal-
fed group, NF), or reduced to three in order to induce OF. At weaning, mice 
of both groups received a standard diet ad libitum (AL). At 6 months of age, 
half of the OF mice were assigned to a moderate 20% calorie restriction 
(CR, OF-CR) for one month, while NF and the other half of the OF mice 
continued to eat ad libitum (NF-AL, OF-AL). Cardiac function was followed 
using echocardiography and, at 7 months, the sensitivity to ischemia-reper-
fusion injury was evaluated in isolated perfused hearts. Six-month-old OF 
mice weighed 22.5% more than NF mice. Left ventricular fractional short-
ening (LVFS) and ejection fraction (LVEF) were decreased in OF mice 
(25.5% vs. 30.5% for LVFS; 50% vs. 58% for LVEF, P<0.05). Left ventric-
ular internal diameter in diastole (LVIDd) and systole (LVIDs) were signif-
icantly greater in OF than NF mice. One month of moderate CR normalized 
body weight in OF-CR compared with OF-AL (31.1 vs. 37.4 g, p<0.001). 
Moreover, LVEF was greater in OF-CR than OF-AL (61% vs. 52%, p<0.05) 
and became comparable to that in NF-AL. LVIDd and LVIDs were also nor-
malized in OF-CR. Ex vivo, after 30 min of global ischemia, hearts isolated 
from OFCR mice showed better functional recovery than those of the two 
other groups. Our study suggests that short-term moderate diet restriction 
could normalize body weight gain induced by postnatal OF and, interest-
ingly, could reverse alterations of cardiac function and susceptibility to 
myocardial ischemia-reperfusion injury in OF.
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